OFDI Imaging for Coronary Artery Disease
Trial Summary
What is the purpose of this trial?
Atherosclerosis, a condition in which fatty deposits of plaque build up along the inner walls of arteries, is a condition that may increase the risk of having a heart attack. Previous studies have shown that the presence of a specific kind of plaque, known as vulnerable plaque, is often found in people who have had a heart attack. This study will use a new imaging technique called optical frequency domain imaging (OFDI) to examine the presence of vulnerable plaques in people with coronary artery disease.
Research Team
Guillermo Tearney, MD, PhD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for people with coronary artery disease who are undergoing a procedure called PCTI. Women of childbearing age must test negative for pregnancy before joining. People can't join if they have kidney issues, recent heart attacks, complex heart lesions, severe vascular disease, congestive heart failure, previous bypass surgery or are in another study.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- OFDI imaging (Imaging Technique)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator